| Primary |
| Drug Use For Unknown Indication |
24.7% |
| Product Used For Unknown Indication |
13.8% |
| Medication Dilution |
8.9% |
| Adenocarcinoma |
5.7% |
| Colorectal Cancer Metastatic |
5.3% |
| Ovarian Cancer |
4.9% |
| Fluid Replacement |
4.0% |
| Parathyroidectomy |
4.0% |
| Surgery |
4.0% |
| Anaesthesia |
3.2% |
| Chemotherapy |
3.2% |
| Rectal Cancer |
3.2% |
| Intravenous Catheter Management |
2.8% |
| Colorectal Cancer |
2.4% |
| Gastrointestinal Carcinoma |
2.4% |
| Endometrial Cancer |
1.6% |
| Nausea |
1.6% |
| Thermal Burn |
1.6% |
| Bacteraemia |
1.2% |
| Colon Cancer |
1.2% |
|
| Chills |
20.4% |
| Tremor |
14.6% |
| Anaphylactic Reaction |
11.7% |
| Vomiting |
10.7% |
| Pyrexia |
6.8% |
| Bronchospasm |
4.9% |
| Type Iv Hypersensitivity Reaction |
4.9% |
| Dyspnoea |
2.9% |
| Incorrect Drug Administration Rate |
2.9% |
| Localised Oedema |
2.9% |
| White Blood Cell Count Increased |
2.9% |
| Accidental Exposure |
1.9% |
| Chest Pain |
1.9% |
| Myocardial Infarction |
1.9% |
| Pulmonary Embolism |
1.9% |
| Scar |
1.9% |
| Shock |
1.9% |
| Blood Pressure Decreased |
1.0% |
| Death |
1.0% |
| Drug Ineffective |
1.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.4% |
| Osteomyelitis |
8.0% |
| Prophylaxis Of Nausea And Vomiting |
8.0% |
| Caesarean Section |
7.4% |
| Prophylaxis |
7.4% |
| Product Used For Unknown Indication |
5.8% |
| Anaesthesia |
5.4% |
| Neuroendocrine Carcinoma |
4.2% |
| Pneumocystis Jiroveci Pneumonia |
4.2% |
| Drug Toxicity |
3.2% |
| Cholinergic Syndrome |
2.6% |
| Fluid Replacement |
2.6% |
| Fungal Infection |
2.6% |
| Therapeutic Procedure |
2.6% |
| Intravenous Catheter Management |
2.2% |
| Antifungal Prophylaxis |
1.9% |
| Cardiomyopathy |
1.9% |
| Neuroblastoma |
1.9% |
| Ovarian Cancer |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
|
| Disseminated Intravascular Coagulation |
20.6% |
| Tremor |
13.2% |
| Chills |
10.3% |
| Bronchospasm |
7.4% |
| Thrombocytopenia |
7.4% |
| Vomiting |
5.9% |
| Partial Seizures |
4.4% |
| Syncope |
4.4% |
| Haematotoxicity |
2.9% |
| Leukopenia |
2.9% |
| Myocardial Infarction |
2.9% |
| Myofascial Pain Syndrome |
2.9% |
| Renal Failure Acute |
2.9% |
| Toxic Epidermal Necrolysis |
2.9% |
| Anaemia |
1.5% |
| Blood Potassium Decreased |
1.5% |
| Cardiac Arrest |
1.5% |
| Circumstance Or Information Capable Of Leading To Medication Error |
1.5% |
| Diarrhoea |
1.5% |
| Drug Administration Error |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.6% |
| Product Used For Unknown Indication |
22.2% |
| Prophylaxis |
11.4% |
| Fluid Replacement |
3.9% |
| Abdominal Pain |
3.3% |
| Pain |
3.2% |
| Hypertension |
2.9% |
| Sedation |
2.8% |
| Pancreatic Pseudocyst |
2.7% |
| Infection |
2.0% |
| Decreased Appetite |
2.0% |
| Diuretic Therapy |
1.8% |
| Vitamin Supplementation |
1.7% |
| Infection Prophylaxis |
1.5% |
| Pneumonia |
1.5% |
| Nausea |
1.5% |
| Constipation |
1.3% |
| Premedication |
1.3% |
| Gastric Cancer |
1.3% |
| Labour Stimulation |
1.2% |
|
| Vomiting |
14.6% |
| Respiratory Failure |
13.9% |
| Sepsis |
9.9% |
| Weight Decreased |
5.3% |
| Pleural Effusion |
4.6% |
| Septic Shock |
4.6% |
| Loss Of Consciousness |
4.0% |
| Thrombocytopenia |
4.0% |
| Urinary Tract Infection |
4.0% |
| Convulsion |
3.3% |
| Decreased Appetite |
3.3% |
| Female Genital Tract Fistula |
3.3% |
| Intestinal Fistula |
3.3% |
| Pneumonia Cryptococcal |
3.3% |
| Pulmonary Embolism |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Traumatic Brain Injury |
3.3% |
| Vaginal Fistula |
3.3% |
| Atrial Fibrillation |
2.6% |
| Blood Glucose Increased |
2.6% |
|
